Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rehli

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Cancer Immunology Research|February 10, 2021
The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated MacrophagesDimitrios Mougiakakos, Christian Bach, Martin Böttcher, et al.
Immunity|March 31, 2021
Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cellsMichael Delacher, Malte Simon, Lieke Sanderink, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Journal for Immunotherapy of Cancer|May 23, 2022
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activationAntonio Sorrentino, Ayse Nur Menevse, Tillmann Michels, et al.
Cell|September 14, 2024
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacyJeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, et al.
Nature Immunology|July 16, 2025
DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterpartsNiklas Beumer, Charles D Imbusch, Tamara Kaufmann, et al.
Signal Transduction and Targeted Therapy|August 8, 2024
LIM-domain-only 4 (LMO4) enhances CD8<sup>+</sup> T-cell stemness and tumor rejection by boosting IL-21-STAT3 signalingRoland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, et al.
The Journal of Experimental Medicine|January 16, 2024
The effector program of human CD8 T cells supports tissue remodelingMichael Delacher, Lisa Schmidleithner, Malte Simon, et al.
Cell|May 1, 2026
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapseLuca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.
Plos Computational Biology|March 2, 2018
Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human diseaseJ Kenneth Baillie, Andrew Bretherick, Christopher S Haley, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Cancer Immunology Research|February 10, 2021
The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated MacrophagesDimitrios Mougiakakos, Christian Bach, Martin Böttcher, et al.
Immunity|March 31, 2021
Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cellsMichael Delacher, Malte Simon, Lieke Sanderink, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Journal for Immunotherapy of Cancer|May 23, 2022
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activationAntonio Sorrentino, Ayse Nur Menevse, Tillmann Michels, et al.
Cell|September 14, 2024
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacyJeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, et al.
Nature Immunology|July 16, 2025
DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterpartsNiklas Beumer, Charles D Imbusch, Tamara Kaufmann, et al.
Signal Transduction and Targeted Therapy|August 8, 2024
LIM-domain-only 4 (LMO4) enhances CD8<sup>+</sup> T-cell stemness and tumor rejection by boosting IL-21-STAT3 signalingRoland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, et al.
The Journal of Experimental Medicine|January 16, 2024
The effector program of human CD8 T cells supports tissue remodelingMichael Delacher, Lisa Schmidleithner, Malte Simon, et al.
Cell|May 1, 2026
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapseLuca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.
Plos Computational Biology|March 2, 2018
Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human diseaseJ Kenneth Baillie, Andrew Bretherick, Christopher S Haley, et al.
Pageof 12